Osanni Bio
PrivateLast Round
Series B
Jun 23, 2026
Total Funding Raised
$217M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Osanni Bio is a biotechnology company that operates a development-stage therapeutics platform to discover and develop new medicines, with programs in ophthalmology, cardiology, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osanni Bio Comparables
Compare Osanni Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PureTech Health | 83% | |
| Retromer Therapeutics | 82% | |
| Eli Lilly and Company | 74% |
Osanni Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 23, 2026 | ||||
| Seed | Oct 1, 2022 |
Key People
Founding team and executive leadership
Osanni Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horowitz Group | Series A, Seed, Series B |
| Patient Square Capital | Series B |
| Invus Opportunities | Series A, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 25% QoQ, from 28 to 35 employees.
- Jun 23, 2026
$190M round led by Patient Square Capital
Recent news
Latest coverage and updates
- is_developingJun 23, 2026
Osanni is developing model for discovering and developing innovative medicines for patients with significant unmet need on Jun 23rd '26.
- receives_financingJun 23, 2026
Osanni Bio received financing of $190M in Series B on Jun 23rd '26.
Osanni Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Osanni Bio's valuation, stock price, and market status.
Is Osanni Bio a public or private company?
Osanni Bio is a private company.
What is the current stock price of Osanni Bio?
Osanni Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Osanni Bio worth (valuation)?
Valuation information for Osanni Bio is not publicly available.
Can I buy Osanni Bio stock?
Osanni Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Osanni Bio's last funding round?
Osanni Bio's most recent funding round was Series B on June 23, 2026.
Who are the main investors in Osanni Bio?
Key investors in Osanni Bio include Patient Square Capital.
Will Osanni Bio IPO soon?
No public IPO plans have been announced for Osanni Bio.
How can I track Osanni Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Osanni Bio's secondary market activity and sign up for updates.